Skip to main content
logo
Mersana Therapeutics, Inc. (MRSN)
Jan 6, 2026 - MRSN was delisted (reason: acquired by DAWN)
29.08
+0.04 (0.14%)
Inactive · Last trade price on Jan 5, 2026

Mersana Therapeutics Revenue

Mersana Therapeutics had revenue of $11.01M in the quarter ending September 30, 2025, a decrease of -12.61%. This brings the company's revenue in the last twelve months to $33.18M, down -4.76% year-over-year. In the year 2024, Mersana Therapeutics had annual revenue of $40.50M with 9.88% growth.

Revenue (ttm)
$33.18M
Revenue Growth
-4.76%
P/S Ratio
4.36
Revenue / Employee
$325,294
Employees
102
Market Cap
145.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202440.50M3.64M9.88%
Dec 31, 202336.86M10.27M38.65%
Dec 31, 202226.58M26.54M61,716.28%
Dec 31, 202143.00K-785.00K-94.81%
Dec 31, 2020828.00K-41.30M-98.03%
Dec 31, 201942.12M31.53M297.61%
Dec 31, 201810.59M-6.95M-39.62%
Dec 31, 201717.55M-7.63M-30.30%
Dec 31, 201625.17M14.81M142.99%
Dec 31, 201510.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

MRSN News

More News